Mitophagy and Disease: New Avenues for Pharmacological Intervention

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|20|2056-2073

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.20, 2011-07, pp. : 2056-2073

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New pharmacological avenues for the treatment of l-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors

By Blandini Fabio   Armentero Marie-Therese  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 153-168

Informa Healthcare

Access to resources Recommend Favorite

New Molecular Avenues in Parkinson’s Disease Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 10, 2009-07 ,pp. : 913-948

Bentham Science Publishers

Access to resources Recommend Favorite

Hypertension and Hypercholesterolaemia as Risk Factors for Alzheimer's Disease: Potential for Pharmacological Intervention

By Kivipelto M.  

CNS Drugs, Vol. 16, Iss. 7, 2002-01 ,pp. : 435-444

Adis International

Access to resources Recommend Favorite

Cholinergic Nicotinic Systems in Alzheimer's Disease: Prospects for Pharmacological Intervention

By Vesey R.  

CNS Drugs, Vol. 16, Iss. 7, 2002-01 ,pp. : 485-500

Adis International

Access to resources Recommend Favorite

Pharmacological intervention with 5-lipoxygenase: new insights and novel compounds

By Werz Oliver   Steinhilber Dieter  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 5, 2005-05 ,pp. : 505-519

Informa Healthcare

Access to resources Recommend Favorite